+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

EuroPCR 2023: COAPT 5-year follow-up

AV VALVES 2023: Staged, Concomitant

Navitor™: Voice of the Experts Francesco Nicolas Dumonteil

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

TAVI with Navitor Vision - Livecase

ESC 2023 Tutorial – TriClip™ | Prof. Donal

EACTS 2021: MVR Guidelines update

PCR London Valves 2022 – Tricuspid valve intervention

TAVI 2023: Optimizing TAVI

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

Tendyne™: 6-Year Outcomes

EXPAND Study: Data overview

PCR LV 2021: Navitor™ 30-day outcomes

PCRLV 2022: bRIGHT 30 days

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Cardiac imaging and morphology

Trending Controversies | AV Valves

Review the Trends | Mitral focus

TAVI Summit 2023: Morphology

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline